Retinyl Palmitate
RETINYL PALMITATE (INCI: RETINYL PALMITATE) is an ingredient of plant, synthetic, or animal origin. It is used as a skin care agent.
Roles & functions
Skin conditioning — Keeps the skin in good condition and protects it; improves its comfort.
Safety limit not to exceed
| Population | Limit / day | Type of reference | Source |
|---|---|---|---|
| Adult · general population | 3000 µg RE | Tolerable Upper Intake Level (UL) | EFSA NDA 2024 (EFSA J 22(6):8814) |
| Pregnancy | 3000 µg RE | Tolerable Upper Intake Level (UL) | EFSA NDA 2024 (EFSA J 22(6):8814) |
| Breastfeeding | 3000 µg RE | Tolerable Upper Intake Level (UL) | EFSA NDA 2024 (EFSA J 22(6):8814) |
| From 12 months to 47 months | 800 µg RE | Tolerable Upper Intake Level (UL) | EFSA NDA 2024 (EFSA J 22(6):8814) |
| From 4 years to 83 months | 1100 µg RE | Tolerable Upper Intake Level (UL) | EFSA NDA 2024 (EFSA J 22(6):8814) |
| From 7 years to 131 months | 1500 µg RE | Tolerable Upper Intake Level (UL) | EFSA NDA 2024 (EFSA J 22(6):8814) |
| From 11 years to 179 months | 2000 µg RE | Tolerable Upper Intake Level (UL) | EFSA NDA 2024 (EFSA J 22(6):8814) |
| From 15 years to 215 months | 2600 µg RE | Tolerable Upper Intake Level (UL) | EFSA NDA 2024 (EFSA J 22(6):8814) |
Official reference limit, for information only, this is not personalised advice. Ask a pharmacist about your situation.
Last verified :
What the authorities say
| Authority | Status |
|---|---|
| Commission européenne (CosIng, Règl. 1223/2009) | Autorisé sous conditions |
| CLP classification (Reg. 1272/2008) | No CMR classification |
| ECHA — endocrine disruptor (human health) | Not identified as an endocrine disruptor |
| ECHA — Candidate List (SVHC, REACH Art. 59) | Not on the Candidate List (SVHC) |
| European Commission (Reg. 1223/2009, Annex III) | No cosmetic allergen subject to mandatory labelling |
| European Commission (EU catalogue of nanomaterials, Reg. 1223/2009) | No referenced nanoform |
| European Commission — Annex III (Reg. 1223/2009) — maj Thu, 01 Oct 2026 05:00:28 GMT | Permitted subject to restrictions (Annex III) — max (a) 0,05 % Retinol Equivalent (RE) (b) 0,3 % RE in (a) Body lotion (b) other leave-on and rinse-off products — For any cosmetic product containing Retinol, Retinyl Acetate or Retinyl Palmitate the following, labelling is obligatory: ‘Contains Vitamin A. Consider your daily intake before use’. — From 1 November 2025 cosmetic products containing that substance and not complying with the conditions shall not be placed on the Union market. From 1 May 2027 cosmetic products containing that substance and not complying with the conditions shall not be made available on the Union market. |
What the EFSA says
Yes. Vitamin A contributes to the maintenance of normal skin
Yes. Vitamin A contributes to the maintenance of normal vision
Yes. Vitamin A contributes to the normal function of the immune system
Yes. Vitamin A has a role in the process of cell specialisation
Yes. Vitamin A contributes to normal iron metabolism
Yes. Vitamin A contributes to the maintenance of normal mucous membranes
Source: EFSA / Reg. (EU) 432/2012
Who it is not recommended for
Pendant la grossesse ou un projet de grossesse, un excès de vitamine A peut nuire au développement du bébé. Demandez conseil à votre pharmacien avant de prendre ce complément.
Pendant l'allaitement, mieux vaut éviter les compléments enrichis en vitamine A. Demandez conseil à votre pharmacien.
Products containing it
In Lou’s database
| Most frequent categories | Anti-aging · Serums · Eye contour · Hydration · Lips |
| Most frequent brands | Uriage · Bi-Oil · Biotherm · Eneomey · Fortimel |
A question about this ingredient?
Lou answers you and looks at your products with you, in store.